Not Yet RecruitingNot Applicable

Communication Regarding Preclinical Dementia Diagnostic and Diagnostic Disclosure Among Patients with MCI and SCD

120 participantsStarted 2024-10-15

Plain-language summary

The study investigate what information individuals with SCD or MCI and their co-participant would like to receive during pre-diagnostic counseling and diagnostic disclosure, and how this information should be conveyed.

Who can participate

Age range

40 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with SCD or MCI * Lumbar puncture performed during the diagnostic process * Age at or below 80 years * MMSE at or above 24 Exclusion Criteria: * Diagnosis of current major psychiatric disorder (schizophrenia, bipolar disorder, psychosis) * Current excessive alcohol intake or substance abuse Inclusion criteria for the co-participant: * Attended the diagnostic disclosure visit together with the individual diagnosed with SCD or MCI

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Important issues in communication

Timeframe: From enrollment to the second questionnaire after 6 weeks

Trial details

NCT IDNCT06621758

SponsorDanish Dementia Research Centre

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2026-02-01

Contact for this trial

Marie Bruun, MD, PhD

+45 35451910 marie.bruun@regionh.dk

View on ClinicalTrials.gov More Alzheimer Disease trials

Who can participate

Age range

40 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.